115 related articles for article (PubMed ID: 20823033)
1. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1.
Ullrich NJ; Zimmerman M; Smith E; Irons M; Marcus K; Kieran MW
J Child Neurol; 2011 Feb; 26(2):228-30. PubMed ID: 20823033
[TBL] [Abstract][Full Text] [Related]
2. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1.
El-Koussy M; Lövblad KO; Steinlin M; Kiefer C; Schroth G
Neuroradiology; 2002 Nov; 44(11):938-41. PubMed ID: 12428131
[TBL] [Abstract][Full Text] [Related]
3. Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.
Arita H; Narita Y; Ohno M; Miyakita Y; Okita Y; Ide T; Shibui S
Childs Nerv Syst; 2013 Feb; 29(2):341-5. PubMed ID: 23108917
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report.
Serdaroğlu A; Simşek F; Gücüyener K; Oğuz A; Karadeniz C; Balibey M
J Child Neurol; 2000 Nov; 15(11):765-7. PubMed ID: 11108514
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
Rosser TL; Vezina G; Packer RJ
Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature.
Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A
Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349
[TBL] [Abstract][Full Text] [Related]
7. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 association with moyamoya disease.
Koc F; Yerdelen D; Koc Z
Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya disease in a child with neurofibromatosis type-1.
Kwong KL; Wong YC
J Paediatr Child Health; 1999 Feb; 35(1):108-9. PubMed ID: 10234650
[No Abstract] [Full Text] [Related]
10. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya syndrome associated with systemic lupus erythematosus.
Jeong HC; Kim YJ; Yoon W; Joo SP; Lee SS; Park YW
Lupus; 2008 Jul; 17(7):679-82. PubMed ID: 18625642
[TBL] [Abstract][Full Text] [Related]
12. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
Serafini NB; Serafini CB; Vinhas AS; Godinho MB
An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
[TBL] [Abstract][Full Text] [Related]
13. Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.
Hakan T; Aker FV
Neurol Neurochir Pol; 2008; 42(4):362-5. PubMed ID: 18975243
[TBL] [Abstract][Full Text] [Related]
14. Moyamoya syndrome related to neurofibromatosis of type 1: a case report.
Delvoye F; Hervé D; Chabriat H; Mawet J
Acta Neurol Belg; 2013 Dec; 113(4):539-41. PubMed ID: 24085541
[No Abstract] [Full Text] [Related]
15. [Multiple progressive cerebral arterial stenoses, stenosis of renal artery and Recklinghausen's disease. Apropos of a case of moyamoya in an infant].
Gilly R; Elbaz N; Langue J; Raveau J
Pediatrie; 1982; 37(7):523-30. PubMed ID: 6820491
[No Abstract] [Full Text] [Related]
16. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya syndrome and neurofibromatosis type 1.
Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
[TBL] [Abstract][Full Text] [Related]
18. Progressive unilateral hemispheric atrophy in an infant with neurofibromatosis.
Wintermark P; Meagher-Villemure K; Villemure JG; Maeder-Ingvar M; Maeder P; Ghariani S; Roulet-Perez E
Neuropediatrics; 2007 Apr; 38(2):100-4. PubMed ID: 17712739
[TBL] [Abstract][Full Text] [Related]
19. Poor wound healing after pial synangiosis in 2 children with moyamoya vasculopathy associated with neurofibromatosis type 1.
Golomb MR; Smith JL
J Child Neurol; 2014 Oct; 29(10):NP101-4. PubMed ID: 24141273
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya disease with concurrent von Recklinghausen's disease and cerebral arteriovenous malformation.
Hattori S; Kiguchi H; Ishii T; Nakajima T; Yatsuzuka H
Pathol Res Pract; 1998; 194(5):363-9. PubMed ID: 9651950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
